TRENTON, N.J. (AP) — U.S. regulators have approved a new tuberculosis medicine that shortens and improves treatment for the hardest-to-treat cases, a worsening problem in many poor countries. It’s the first TB drug developed by a nonprofit group, the TB Alliance, which was formed to come up with better treatments. The Food and Drug Administration […]

This story is from The Seattle Times. Read the rest of this News story at https://www.seattletimes.com/business/fda-approves-tb-pill-that-cures-more-hard-to-treat-patients/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_seattle-news.

This post was originally published on this site